Statin use and pancreatic cancer risk in two prospective cohort studies

被引:0
作者
Tsuyoshi Hamada
Natalia Khalaf
Chen Yuan
Ana Babic
Vicente Morales-Oyarvide
Zhi Rong Qian
Jonathan Andrew Nowak
Kimmie Ng
Peter Kraft
Douglas Adam Rubinson
Meir Jonathan Stampfer
Edward Luciano Giovannucci
Charles Stewart Fuchs
Shuji Ogino
Brian Matthew Wolpin
机构
[1] Dana-Farber Cancer Institute and Harvard Medical School,Department of Oncologic Pathology
[2] Brigham and Women’s Hospital and Harvard Medical School,Division of Gastroenterology, Hepatology, and Endoscopy
[3] Dana-Farber Cancer Institute and Harvard Medical School,Department of Medical Oncology
[4] Harvard T.H. Chan School of Public Health,Department of Epidemiology
[5] Brigham and Women’s Hospital and Harvard Medical School,Program in MPE Molecular Pathological Epidemiology, Department of Patholog
[6] Harvard T.H. Chan School of Public Health,Department of Biostatistics
[7] Brigham and Women’s Hospital and Harvard Medical School,Channing Division of Network Medicine, Department of Medicine
[8] Harvard T.H. Chan School of Public Health,Department of Nutrition
[9] Yale Cancer Center,Department of Medicine
[10] Yale School of Medicine,undefined
[11] Smilow Cancer Hospital,undefined
来源
Journal of Gastroenterology | 2018年 / 53卷
关键词
Chemoprevention; Cohort studies; Hydroxymethylglutaryl-CoA reductase inhibitors; Pancreatic neoplasms; Risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:959 / 966
页数:7
相关论文
共 106 条
  • [1] Siegel RL(2017)Cancer Statistics, 2017 CA Cancer J Clin 67 7-30
  • [2] Miller KD(2012)Pharmacological actions of statins: a critical appraisal in the management of cancer Pharmacol Rev 64 102-146
  • [3] Jemal A(2005)Statins and cancer prevention Nat Rev Cancer 5 930-942
  • [4] Gazzerro P(2013)Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates Nat Rev Clin Oncol 10 625-642
  • [5] Proto MC(2014)Novel prospects of statins as therapeutic agents in cancer Pharmacol Res 88 84-98
  • [6] Gangemi G(2015)The effect of statins on cancer cells–review Tumour Biol 36 4889-4904
  • [7] Demierre MF(2016)The interplay between cell signalling and the mevalonate pathway in cancer Nat Rev Cancer 16 718-731
  • [8] Higgins PD(2016)Pancreatic cancer chemoprevention translational workshop: meeting report Pancreas 45 1080-1091
  • [9] Gruber SB(2016)Statins and the risk of pancreatic cancer in type 2 diabetic patients—a population-based cohort study Int J Cancer 138 594-603
  • [10] Gronich N(2013)The differential effects of statins on the risk of developing pancreatic cancer: a case–control study in two centres in the United Kingdom Dig Dis Sci 58 3308-3312